ISOSULFAN BLUE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for isosulfan blue and what is the scope of freedom to operate?

Isosulfan blue is the generic ingredient in two branded drugs marketed by Am Regent, Beloteca, Eugia Pharma, Fresenius Kabi Usa, Meitheal, MSN, Mylan Institutional, Somerset Theraps Llc, and Covidien, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for isosulfan blue. Five suppliers are listed for this compound.

Summary for ISOSULFAN BLUE

US Patents:	0
Tradenames:	2
Applicants:	9
NDAs:	9
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	5
Raw Ingredient (Bulk) Api Vendors:	41
Clinical Trials:	15
Patent Applications:	604
Drug Prices:	Drug price trends for ISOSULFAN BLUE
What excipients (inactive ingredients) are in ISOSULFAN BLUE?	ISOSULFAN BLUE excipients list
DailyMed Link:	ISOSULFAN BLUE at DailyMed

See drug prices for ISOSULFAN BLUE

Recent Clinical Trials for ISOSULFAN BLUE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Institutes of Health (NIH)	N/A
University of Wisconsin, Madison	N/A
OnLume Inc.	N/A

See all ISOSULFAN BLUE clinical trials

US Patents and Regulatory Information for ISOSULFAN BLUE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Covidien	LYMPHAZURIN	isosulfan blue	SOLUTION;SUBCUTANEOUS	018310-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Somerset Theraps Llc	ISOSULFAN BLUE	isosulfan blue	SOLUTION;SUBCUTANEOUS	210558-001	Jul 12, 2019		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Beloteca	ISOSULFAN BLUE	isosulfan blue	SOLUTION;SUBCUTANEOUS	210714-001	Jan 16, 2019		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.